Platinum Investment Management LTD Bicycle Therapeutics PLC Transaction History
Platinum Investment Management LTD
- $2.16 Billion
- Q3 2024
A detailed history of Platinum Investment Management LTD transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Platinum Investment Management LTD holds 272,149 shares of BCYC stock, worth $3.53 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
272,149
Previous 293,445
7.26%
Holding current value
$3.53 Million
Previous $5.94 Million
3.92%
% of portfolio
0.29%
Previous 0.24%
Shares
5 transactions
Others Institutions Holding BCYC
# of Institutions
113Shares Held
40.8MCall Options Held
39.6KPut Options Held
24.6K-
Baker Bros. Advisors LP New York, NY9.4MShares$122 Million2.28% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.55MShares$46.1 Million2.97% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.34MShares$30.4 Million9.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.25MShares$29.2 Million0.71% of portfolio
-
Armistice Capital, LLC New York, NY1.96MShares$25.4 Million0.74% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $385M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...